Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Ak

Akero Therapeutics Inc

AKRO · NASDAQ
AKRO · NASDAQ

Next Earnings: 26 Feb 2025

30.96
USD-0.11-0.34%

Analysts Recommendations

Bullish

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Day Range

30.66USD
31.89USD

52 Week Range

15.32USD
37.00USD

Market Cap

2.17BUSD

About

General Information

Type

Common Stock

Exchange

NASDAQ

Currency Code

USD

Currency Name

US Dollar

Country Name

USA

Country ISO

US

ISIN

US00973Y1082

CUSIP

00973Y108

Sector

Healthcare

Industry

Biotechnology

Fiscal Year End

December

IPO date

-

Updated At

-

Highlights

PE Ratio

-

PEG Ratio

-

Book Value

10.61

Dividend Share

-

Dividend Yield

-

Earnings Share

-3.78

Wall Street Target Price

48.2727

EPS Estimate Current Year

-3.9703

EPS Estimate Next Year

-4.8687

EPS Estimate Current Quarter

-0.9

EPS Estimate Next Quarter

-0.95

Most Recent Quarter

-

Profitability

Revenue TTM

0

Gross Profit TTM

0

EBITDA

-269,265,984

Profit Margin

0.00%

Return On Assets TTM

-23.17%

Return On Equity TTM

-35.90%

Revenue Per Share TTM

0

Qtly Revenue Growth YOY

0.00%

Diluted Eps TTM

-3.78

Qtly Earnings Growth YOY

0.00%

Valuation

Trailing PE

0.00

Forward PE

0

Price Sales TTM

0

Price Book MRQ

2.9411

Enterprise Value Revenue

0

Enterprise Value EBITDA

-6

Peers analysis

  • Vertex Pharmaceuticals Inc
    VRTXVertex Pharmaceuticals Inc

    474.19

    2.68%
  • Regeneron Pharmaceuticals Inc
    REGNRegeneron Pharmaceuticals Inc

    788.01

    1.27%
  • BeiGene Ltd
    BGNEBeiGene Ltd

    207.96

    1.13%
  • argenx SE
    ARGNFargenx SE

    525.60

    0.00%
  • CSL Limited
    CMXHFCSL Limited

    170.35

    -5.37%
  • argenx NV ADR
    ARGXargenx NV ADR

    616.84

    -1.11%
  • CSL Ltd
    CSLLYCSL Ltd

    89.57

    -0.99%
  • BioNTech SE
    BNTXBioNTech SE

    121.19

    -0.44%
  • Alnylam Pharmaceuticals Inc
    ALNYAlnylam Pharmaceuticals Inc

    255.48

    -0.31%
  • UCB SA ADR
    UCBJYUCB SA ADR

    98.13

    -0.03%